Search Results - Andrew L. Gilman

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections

    Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections by Lei Bao, Morton J. Cowan, Kimberly Dunham, Biljana Horn, Joseph P. McGuirk, Andrew L. Gilman, Kenneth G. Lucas

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Altered Toll-Like Receptor 9 Responses in Circulating B Cells at the Onset of Extensive Chronic Graft-versus-Host Disease

    Altered Toll-Like Receptor 9 Responses in Circulating B Cells at the Onset of Extensive Chronic Graft-versus-Host Disease by Kevin She, Andrew L. Gilman, Soudabeh Aslanian, Hiromi Shimizu, Mark Krailo, Zhengjia Chen, Gregor S. D. Reid, Donna A. Wall, Fred Goldman, Kirk R. Schultz

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Hydroxychloroquine for the treatment of chronic graft-versus-host disease

    Hydroxychloroquine for the treatment of chronic graft-versus-host disease by Andrew L. Gilman, Ka-Wah Chan, Mark Mogul, Christopher Morris, Frederick D. Goldman, Michael Boyer, E Cirenza, Amitabha Mazumder, Edmund A. Gehan, Ronan A. Cahill, Stanley Frankel, Kirk R. Schultz

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group

    Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem... by Andrew L. Gilman, M. Fevzi Özkaynak, Katherine K. Matthay, Mark Krailo, Alice L. Yu, Jacek Gan, Adam Sternberg, Jacquelyn A. Hank, Robert C. Seeger, Gregory H. Reaman, Paul M. Sondel

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders

    Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders by Lisa Madden, Robert J. Hayashi, Ka Wah Chan, Michael A. Pulsipher, Dorothea Douglas, Gregory A. Hale, Sonali Chaudhury, Paul R. Haut, Kimberly A. Kasow, Andrew L. Gilman, Lisa Murray, Shalini Shenoy

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A survey of diagnosis, management, and grading of chronic GVHD

    A survey of diagnosis, management, and grading of chronic GVHD by Stephanie J. Lee, Georgia B. Vogelsang, Andrew L. Gilman, Daniel J. Weisdorf, Steven Z. Pavletic, Joseph H. Antin, Mary M. Horowitz, Görgün Akpek, Mary E.D. Flowers, Daniel R. Couriel, Paul J. Martin

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group

    Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group by Hisaki Fujii, Geoff D.E. Cuvelier, Kevin She, Soudabeh Aslanian, Hiromi Shimizu, Amina Kariminia, Mark Krailo, Zhengjia Chen, Rob McMaster, Axel Bergman, Frederick D. Goldman, Stephen Grupp, Donna A. Wall, Andrew L. Gilman, Kirk R. Schultz

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study

    Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study by Andrew L. Gilman, Kirk R. Schultz, Frederick D. Goldman, George E. Sale, Mark Krailo, Zhengjia Chen, Bryan Langholz, David A. Jacobsohn, Ka-Wah Chan, Robin Ryan, Michael Kellick, Steven Neudorf, Kamar Godder, Eric Sandler, Indira Sahdev, Stephan A. Grupp, Jean E. Sanders, Donna A. Wall

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931

    A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology... by M. Fevzi Özkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm A. Smith, Karen Messer, Robert C. Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite T. Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

    Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 by Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan, Jacquelyn A. Hank, Ayse Batova, Wendy B. London, Sheena C. Tenney, Malcolm A. Smith, Barry L. Shulkin, Marguerite T. Parisi, Katherine K. Matthay, Susan L. Cohn, John M. Maris, Rochelle Bagatell, Julie R. Park, Paul M. Sondel

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma by Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak, Wendy B. London, Susan G. Kreissman, Helen X. Chen, Malcolm A. Smith, Barry Anderson, Judith G. Villablanca, Katherine K. Matthay, Hiro Shimada, Stephan A. Grupp, Robert C. Seeger, C. Patrick Reynolds, Allen Buxton, Ralph A. Reisfeld, S. D. Gillies, Susan L. Cohn, John M. Maris, Paul M. Sondel

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group

    Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group by Ami V. Desai, Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Wendy B. London, Sheena C. Tenney, Mitchell B. Diccianni, Jacquelyn A. Hank, Marguerite T. Parisi, Barry L. Shulkin, Malcolm A. Smith, Jeffrey A. Moscow, Hiroyuki Shimada, Katherine K. Matthay, Susan L. Cohn, John M. Maris, Rochelle Bagatell, Paul M. Sondel, Julie R. Park, Alice L. Yu

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

    Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group by Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquelyn A. Hank, Mitchell B. Diccianni, Ralph A. Reisfeld, Stephen D. Gillies, Katherine K. Matthay, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Julie R. Park, M. Fevzi Özkaynak, Andrew L. Gilman, Alice L. Yu, Paul M. Sondel

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies

    Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies by Allison A. King, Naynesh Kamani, Nancy Bunin, Indira Sahdev, Joel A. Brochstein, Robert J. Hayashi, Michael Grimley, Allistair Abraham, Jacqueline Dioguardi, Ka Wah Chan, Dorothea Douglas, Roberta H. Adams, Martin Andreánsky, Eric Anderson, Andrew L. Gilman, Sonali Chaudhury, Lolie C. Yu, Jignesh Dalal, Gregory A. Hale, Geoff D.E. Cuvelier, Akshat Jain, Jennifer Krajewski, Alfred P. Gillio, Kimberly A. Kasow, David Delgado, Eric P. Hanson, Lisa Murray, Shalini Shenoy

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-ve... by Steven Z. Pavletic, Paul J. Martin, Stephanie J. Lee, Sandra A. Mitchell, David A. Jacobsohn, Edward W. Cowen, Maria L. Turner, Görgün Akpek, Andrew L. Gilman, George B. McDonald, Mark Schubert, Ann Berger, Peter Bross, Jason W. Chien, Daniel R. Couriel, James P. Dunn, Jane M. Fall‐Dickson, Ann T. Farrell, Mary E.D. Flowers, Hildegard Greinix, Steven Hirschfeld, Lynn H. Gerber, Stella Kim, Robert Knobler, Peter A. Lachenbruch, Frederick W. Miller, Barbara B. Mittleman, Esperanza B. Papadopoulos, Susan K. Parsons, Donna Przepiorka, M. Robinson, Michael E. Ward, Bryce B. Reeve, Lisa G. Rider, Howard M. Shulman, Kirk R. Schultz, Daniel Weisdorf, Georgia B. Vogelsang

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

    Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis by Celalettin Üstün, Andreas Reiter, Bart L. Scott, Ryotaro Nakamura, Gandhi Damaj, Sebastian Kreil, Ryan Shanley, William J. Hogan, Miguel‐Angel Perales, Tsiporah B. Shore, H. Baurmann, Robert K. Stuart, Bernd Gruhn, Michael Doubek, Jack W. Hsu, Eleni Tholouli, Tanja Gromke, Lucy A. Godley, Livio Pagano, Andrew L. Gilman, Eva Wagner, Tor Shwayder, Martin Bornhäuser, Esperanza B. Papadopoulos, Alexandra Böhm, Gregory M. Vercellotti, Maria Teresa Van Lint, Christoph Schmid, Werner Rabitsch, Vinod Pullarkat, Faézeh Legrand, Ibrahim Yakoub‐Agha, Wael Saber, J. Carl Barrett, Olivier Hermine, Hans Hägglund, Wolfgang R. Sperr, Uday Popat, Edwin P. Alyea, Steven M. Devine, H. Joachim Deeg, Daniel J. Weisdorf, Cem Akin, Peter Valent

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: